<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Alzheimers Dement (N Y)</journal-id>
<journal-id journal-id-type="iso-abbrev">Alzheimers Dement (N Y)</journal-id>
<journal-title-group>
<journal-title>Alzheimer's &amp; Dementia : Translational Research &amp; Clinical Interventions</journal-title>
</journal-title-group>
<issn pub-type="epub">2352-8737</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31890855</article-id>
<article-id pub-id-type="pmc">6926344</article-id>
<article-id pub-id-type="publisher-id">S2352-8737(19)30064-2</article-id>
<article-id pub-id-type="doi">10.1016/j.trci.2019.09.004</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Featured Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Estrogen activates Alzheimer's disease genes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="au1">
<name>
<surname>Ratnakumar</surname>
<given-names>Abhirami</given-names>
</name>
<email>abhirami.ratnakumar@gmail.com</email>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="corresp" rid="cor1">∗</xref>
</contrib>
<contrib contrib-type="author" id="au2">
<name>
<surname>Zimmerman</surname>
<given-names>Samuel E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
</contrib>
<contrib contrib-type="author" id="au3">
<name>
<surname>Jordan</surname>
<given-names>Bryen A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">b</xref>
<xref ref-type="aff" rid="aff3">c</xref>
</contrib>
<contrib contrib-type="author" id="au4">
<name>
<surname>Mar</surname>
<given-names>Jessica C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="aff" rid="aff4">d</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>a</label>Department of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY, USA</aff>
<aff id="aff2"><label>b</label>Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY, USA</aff>
<aff id="aff3"><label>c</label>Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA</aff>
<aff id="aff4"><label>d</label>Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, Australia</aff>
<author-notes>
<corresp id="cor1"><label>∗</label>Corresponding author. <email>abhirami.ratnakumar@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>09</day>
<month>12</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>5</volume>
<fpage>906</fpage>
<lpage>917</lpage>
<permissions>
<copyright-statement>© 2019 The Authors</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="abs0010">
<sec>
<title>Introduction</title>
<p>Women are at increased risk for Alzheimer's disease (AD), but the reason why remains unknown. One hypothesis is that low estrogen levels at menopause increases vulnerability to AD, but this remains unproven.</p>
</sec>
<sec>
<title>Methods</title>
<p>We compared neuronal genes upregulated by estrogen in ovariectomized female rhesus macaques with a database of &gt;17,000 diverse gene sets and applied a rare variant burden test to exome sequencing data from 1208 female AD patients with the age of onset &lt; 75 years and 2162 female AD controls.</p>
</sec>
<sec>
<title>Results</title>
<p>We found a striking overlap between genes upregulated by estrogen in macaques and genes downregulated in the human postmortem AD brain, and we found that estrogen upregulates the <italic>APOE</italic> gene and that progesterone acts antagonistically to estrogen genome-wide. We also found that female patients with AD have excess rare mutations in the early menopause gene <italic>MCM8</italic>.</p>
</sec>
<sec>
<title>Discussion</title>
<p>We show with genomic data that the menopausal loss of estrogen could underlie the increased risk for AD in women.</p>
</sec>
</abstract>
<kwd-group id="kwrds0010">
<title>Keywords</title>
<kwd>Estrogen</kwd>
<kwd>Menopause</kwd>
<kwd>Mitochondria</kwd>
<kwd>
<italic>APOE</italic>
</kwd>
<kwd>
<italic>MCM8</italic>
</kwd>
<kwd>
<italic>ASPM</italic>
</kwd>
<kwd>
<italic>SORL1</italic>
</kwd>
<kwd>
<italic>ABCA7</italic>
</kwd>
<kwd>Genetics</kwd>
<kwd>Women</kwd>
<kwd>HRT</kwd>
<kwd>Hormone replacement therapy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1">
<label>1</label>
<title>Introduction</title>
<p id="p0010">Two-thirds of approximately 5.4 million Americans with Alzheimer's disease (AD) are women [<xref ref-type="bibr" rid="bib1">1</xref>]. Women are at increased risk for AD, even after adjusting for age and education level [<xref ref-type="bibr" rid="bib1">[1]</xref>, <xref ref-type="bibr" rid="bib2">[2]</xref>, <xref ref-type="bibr" rid="bib3">[3]</xref>]. Moreover, while <italic>APOE</italic> is the largest known genetic susceptibility factor for AD [<xref ref-type="bibr" rid="bib4">4</xref>], women with the risk allele have much higher risk for disease than men [<xref ref-type="bibr" rid="bib5">[5]</xref>, <xref ref-type="bibr" rid="bib6">[6]</xref>, <xref ref-type="bibr" rid="bib7">[7]</xref>]. Various lines of evidence suggest that the menopause transition underlies the increased vulnerability [<xref ref-type="bibr" rid="bib8">[8]</xref>, <xref ref-type="bibr" rid="bib9">[9]</xref>, <xref ref-type="bibr" rid="bib10">[10]</xref>, <xref ref-type="bibr" rid="bib11">[11]</xref>, <xref ref-type="bibr" rid="bib12">[12]</xref>]. <italic>In vitro</italic> studies suggest that estrogen is neuroprotective against various cellular insults [<xref ref-type="bibr" rid="bib13">[13]</xref>, <xref ref-type="bibr" rid="bib14">[14]</xref>, <xref ref-type="bibr" rid="bib15">[15]</xref>, <xref ref-type="bibr" rid="bib16">[16]</xref>, <xref ref-type="bibr" rid="bib17">[17]</xref>, <xref ref-type="bibr" rid="bib18">[18]</xref>] and can also confer protection from amyloid β (Aβ) toxicity [<xref ref-type="bibr" rid="bib19">19</xref>,<xref ref-type="bibr" rid="bib20">20</xref>], whereas postmortem analyses reveal that women with AD have reduced brain estrogen levels [<xref ref-type="bibr" rid="bib21">21</xref>]. Moreover, early surgical removal of ovaries has been linked to cognitive decline [<xref ref-type="bibr" rid="bib22">22</xref>] and increased risk for AD-related dementia [<xref ref-type="bibr" rid="bib23">23</xref>].</p>
<p id="p0015">Hormone replacement therapy (HRT) can alleviate the adverse symptoms of menopause and has been shown to reduce the risk for dementia [<xref ref-type="bibr" rid="bib10">10</xref>,<xref ref-type="bibr" rid="bib11">11</xref>,<xref ref-type="bibr" rid="bib24">[24]</xref>, <xref ref-type="bibr" rid="bib25">[25]</xref>, <xref ref-type="bibr" rid="bib26">[26]</xref>, <xref ref-type="bibr" rid="bib27">[27]</xref>, <xref ref-type="bibr" rid="bib28">[28]</xref>]. However, the overall outcomes are controversial due to the findings of the Women's Health Initiative Memory Study (WHIMS) which showed that HRT increased the risk for dementia [<xref ref-type="bibr" rid="bib29">29</xref>,<xref ref-type="bibr" rid="bib30">30</xref>]. These seemingly contradictory research findings point to significant gaps in our understanding of the effects of estrogen on brain function [<xref ref-type="bibr" rid="bib8">8</xref>,<xref ref-type="bibr" rid="bib9">9</xref>]. Many of these knowledge gaps were recently highlighted by the think tank convened by the Women's Alzheimer's Research Initiative [<xref ref-type="bibr" rid="bib9">9</xref>] and the Society for Women's Health Research Interdisciplinary Network on AD expert panel [<xref ref-type="bibr" rid="bib8">8</xref>]. These include the need to better understand how estrogen influences risk at the molecular level [<xref ref-type="bibr" rid="bib8">8</xref>], the need to resolve discrepancies between animal models and human clinical trials [<xref ref-type="bibr" rid="bib8">8</xref>,<xref ref-type="bibr" rid="bib9">9</xref>], the need to understand the role of progesterone [<xref ref-type="bibr" rid="bib9">9</xref>], and the need to better understand how <italic>APOE</italic> confers female-biased risk [<xref ref-type="bibr" rid="bib8">8</xref>,<xref ref-type="bibr" rid="bib9">9</xref>].</p>
<p id="p0020">A recent hypothesis proposed to explain how menopause increases vulnerability in women suggests that the perimenopause transition is a “bioenergetic transition state” [<xref ref-type="bibr" rid="bib31">[31]</xref>, <xref ref-type="bibr" rid="bib32">[32]</xref>, <xref ref-type="bibr" rid="bib33">[33]</xref>]. This hypothesis proposes that estrogen promotes glucose metabolism via mitochondria [<xref ref-type="bibr" rid="bib34">34</xref>] and that the decline in estrogen levels during perimenopause leads to a switch away from glucose toward ketone bodies as a fuel source [<xref ref-type="bibr" rid="bib35">35</xref>]. Although this hypothesis is supported by a number of animal models [<xref ref-type="bibr" rid="bib32">32</xref>,<xref ref-type="bibr" rid="bib34">34</xref>] and brain-imaging studies [<xref ref-type="bibr" rid="bib31">31</xref>,<xref ref-type="bibr" rid="bib36">36</xref>], the mechanism by which estrogen acts as the master regulator of glucose uptake and mitochondrial function remains unknown [<xref ref-type="bibr" rid="bib37">37</xref>].</p>
<p id="p0025">In this study, we use a unique genomic approach to address some of the recently highlighted research gaps [<xref ref-type="bibr" rid="bib8">8</xref>,<xref ref-type="bibr" rid="bib9">9</xref>]. We integrate multiple data sets to gather genomic evidence for AD sex-biased risk factors. Our data identify target genes of estrogen and progesterone action within neurons, shed light on the cause of female-biased risk of <italic>APOE</italic>, and provide support for the “bioenergetic transition state hypothesis” [<xref ref-type="bibr" rid="bib31">[31]</xref>, <xref ref-type="bibr" rid="bib32">[32]</xref>, <xref ref-type="bibr" rid="bib33">[33]</xref>] by revealing a central role for mitochondrial function in AD.</p>
</sec>
<sec id="sec2">
<label>2</label>
<title>Methods</title>
<sec id="sec2.1">
<label>2.1</label>
<title>Microarray gene expression data</title>
<p id="p0030">We downloaded the data set GSE16169 from the Gene Expression Omnibus [<xref ref-type="bibr" rid="bib38">38</xref>]. We took the mean of the expression values across the two individuals in each treatment and then calculated the estrogen versus placebo fold change by dividing the mean expression values from the estrogen-treated macaques to the mean expression values for the placebo-treated macaques. We calculated the progesterone versus estrogen fold change by dividing the mean expression value of macaques treated with both estrogen and progesterone by the mean expression value of the macaques treated only with estrogen (Please see attached <xref ref-type="sec" rid="appsec1">Supplementary Material</xref> file for more details.)</p>
</sec>
<sec id="sec2.2">
<label>2.2</label>
<title>Exome sequencing data</title>
<p id="p0035">To maximize the power to detect, we only considered white Europeans because they had the largest sample size. We extracted out white Europeans using the self-described race and ethnicity annotation. We then removed samples that were outliers on heterozygosity and outliers on race as determined by principle component analysis, cryptic relatedness, and other quality-control metrics (<xref ref-type="sec" rid="appsec1">Supplementary Material</xref>). We filtered out all <italic>APOE</italic> ε4 homozygote individuals and only retained cases with age of onset &lt; 75 years. We then extracted out singletons and filtered for deleterious variants, which we defined as loss of function, nonsense-mediated decay, annotated as ‘HIGH’ impact by SNPEff (version 4.3) [<xref ref-type="bibr" rid="bib39">39</xref>] or annotated as both missense and probably damaging by Polyphen [<xref ref-type="bibr" rid="bib40">40</xref>]. We only retained singletons not present in thousand genomes [<xref ref-type="bibr" rid="bib41">41</xref>] or EXaC [<xref ref-type="bibr" rid="bib42">42</xref>].</p>
<p id="p0040">We then developed a rare variant association test similar to what was applied to copy number variations in autism [<xref ref-type="bibr" rid="bib43">43</xref>], but we modified it for deleterious singleton SNPs. The female comparison involved female cases (n = 1208) versus female controls (n = 2162), the male comparison involved male cases (n = 953) versus male controls (n = 1495), and total comparison involved total cases (n = 2161) versus total controls (n = 3657). We calculated false discovery rate by randomizing the case-control status as described in the study by Pinto et al. [<xref ref-type="bibr" rid="bib43">43</xref>] 1000 times. The rare variant association test was applied to all protein-coding genes after filtering out genes with less than three samples in either cases or controls with deleterious singletons.</p>
</sec>
</sec>
<sec id="sec3">
<label>3</label>
<title>Results</title>
<sec id="sec3.1">
<label>3.1</label>
<title>Macaque neuronal gene expression data</title>
<p id="p0045">Rhesus macaques have been used to model menopause because they mimic the hormonal changes experienced by women throughout their life course [<xref ref-type="bibr" rid="bib44">44</xref>]. We obtained microarray gene expression data from laser-captured serotonergic neurons from six female rhesus macaques (with ovaries removed) that were deposited in the Gene Expression Omnibus [<xref ref-type="bibr" rid="bib38">38</xref>]. In this study, two macaques received estrogen, two received placebo, and two received estrogen with progesterone. We identified estrogen responsive genes by comparing gene expression patterns in macaques receiving estrogen with the gene expression patterns of macaques receiving placebo. We performed an unbiased genome-wide analysis to explore the role of estrogen in neurons, we did this by obtaining expression values from 15,517 genes which we ranked by calculating the fold change (FC) between estrogen and placebo treatments (<xref ref-type="fig" rid="fig1">Fig. 1</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 1</xref>).<fig id="fig1"><label>Fig. 1</label><caption><p>Heat map of estrogen-induced gene expression values of 15,517 genes in macaque neurons. The three columns represent placebo expression, estrogen expression, and estrogen + progesterone expression: genes were ranked by fold change (FC) of estrogen-induced expression versus placebo expression. The three panels correspond to the top 2000, middle 2000, and bottom 2000 genes ranked by FC of estrogen-treated versus placebo-treated. The figure shows progesterone to be antagonistic to estrogen in the top 2000, middle 2000, and bottom 2000 genes.</p></caption><graphic xlink:href="gr1"></graphic></fig></p>
</sec>
<sec id="sec3.2">
<label>3.2</label>
<title>Estrogen upregulates genes that are downregulated in AD</title>
<p id="p0050">To identify any cellular and molecular pathways that may be enriched among estrogen-regulated genes, we compared the genes with greater than two-fold (FC &gt; 2) upregulation (504 genes) with all 17,779 gene sets in the MSigDB [<xref ref-type="bibr" rid="bib45">[45]</xref>, <xref ref-type="bibr" rid="bib46">[46]</xref>, <xref ref-type="bibr" rid="bib47">[47]</xref>] (a database of annotated gene sets from a variety of biological studies). We performed a hypergeometric ratio test to assess enrichment and found that ranked eighth, with an adjusted <italic>P</italic> value &lt; 4.8 × 10<sup>−12</sup>, was a data set corresponding to genes downregulated in the hippocampus of patients with AD [<xref ref-type="bibr" rid="bib48">48</xref>] (<xref ref-type="sec" rid="appsec1">Supplementary Table 2</xref>). Among the 1027 genes identified in the AD study by Blalock et al. [<xref ref-type="bibr" rid="bib48">48</xref>], 84 genes overlapped with the 504 estrogen upregulated genes (FC &gt; 2). To assess the robustness of these results, we performed the same analysis using genes with FC greater than 1.5 (1222 genes) (<xref ref-type="sec" rid="appsec1">Supplementary Table 3</xref>). This time, the same AD data set from the study by Blalock et al. [<xref ref-type="bibr" rid="bib48">48</xref>], was ranked first (<italic>P</italic> value &lt; 2.7 × 10<sup>−45</sup>), with 226 genes intersecting estrogen upregulated and AD downregulated gene sets (<xref ref-type="sec" rid="appsec1">Supplementary Table 4</xref>). We compared the overlap of all 4 pairwise comparisons of estrogen upregulated and downregulated genes with Alzheimer's upregulated and downregulated genes and confirmed that the largest overlap was between estrogen upregulated and Alzheimer's downregulated genes (<italic>P</italic> value &lt; 8.14 × 10<sup>−15</sup>, <xref ref-type="sec" rid="appsec1">Supplementary Fig. 1</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 5</xref>). To estimate the false discovery rate, we compared the overlap of 100 randomized sets of 504 genes [<xref ref-type="bibr" rid="bib45">45</xref>] and found that none of the 100 randomized gene sets had statistically significant (<italic>P</italic> value &lt; .05) overlap with the AD downregulated gene signature from the study by Blalock et al. [<xref ref-type="bibr" rid="bib48">48</xref>]. These results reveal that genes upregulated by estrogen are highly enriched for genes that are downregulated in human postmortem AD brains.</p>
</sec>
<sec id="sec3.3">
<label>3.3</label>
<title>Mitochondrial genes link estrogen to AD risk</title>
<p id="p0055">To gain insight into underlying mechanisms linking estrogen to AD risk, we compared the 84 genes that intersect estrogen upregulated and AD downregulated genes to pathways in MSigDB [<xref ref-type="bibr" rid="bib45">45</xref>] and found enrichment for mitochondrial function. Ten pathways were annotated to mitochondrial-related descriptions including oxidative phosphorylation (<italic>P</italic> value &lt; 2.8 × 10<sup>−06</sup>), mitochondrial databases (<italic>P</italic> value &lt; 7.6 × 10<sup>−5</sup>), and the tricarboxylic acid cycle (<italic>P</italic> value &lt; .001) (<xref ref-type="sec" rid="appsec1">Supplementary Table 6</xref>). To confirm that this enrichment is driven by genes downregulated in AD, we compared the overlap of estrogen upregulated genes (FC &gt; 2) with mitochondrial genes, which we obtained from MitoCarta [<xref ref-type="bibr" rid="bib49">49</xref>] (<xref ref-type="sec" rid="appsec1">Supplementary Table 7</xref>), and found that the proportion of mitochondrial genes in the 84 intersecting genes was much greater than the proportion of mitochondrial genes in the 504 estrogen upregulated genes (26% vs. 11%, <italic>P</italic> value &lt; .0007, <xref ref-type="sec" rid="appsec1">Supplementary Material</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 7</xref>). These results suggest that mitochondrial pathways are an important mechanism linking estrogen loss to AD risk.</p>
</sec>
<sec id="sec3.4">
<label>3.4</label>
<title>Estrogen upregulates <italic>APOE</italic> and other synapse genes</title>
<p id="p0060">We found estrogen upregulates several amyloid and synapse-related genes. Ranked third in estrogen-induced fold change out of the 15,517 genes, with a log<sub>2</sub>(fold change) of 4.44, was the AD susceptibility gene <italic>APOE</italic> (<xref ref-type="table" rid="tbl1">Table1</xref>). Because a key feature of AD is synapse loss [<xref ref-type="bibr" rid="bib50">50</xref>,<xref ref-type="bibr" rid="bib51">51</xref>], we hypothesized that estrogen responsive genes may be enriched for synaptic function. To test this, we compared synaptic genes (obtained from SynaptomeDB [<xref ref-type="bibr" rid="bib52">52</xref>,<xref ref-type="bibr" rid="bib53">53</xref>], number of genes = 1644) with the 504 estrogen upregulated genes (FC &gt; 2) (<xref ref-type="sec" rid="appsec1">Supplementary Table 4</xref>) and found a significant overlap of 140 genes (28%, <italic>P</italic> value &lt; 2.2e<sup>−16</sup>), which remained significant even after randomization. We also quantified the overlap between the mitochondrial and synapse enrichment and found that synapse genes (n = 1644) overlapped with mitochondrial genes (n = 988) by 253 genes, which is statistically significant with a hypergeometric ratio test (<italic>P</italic> value &lt; 6.17e<sup>−44</sup>). This suggests that estrogen's role in synapse function could at least in part be mediated by the mitochondria.<table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Top 15 estrogen upregulated genes in macaque neurons</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Log<sub>2</sub> (fold change)</th><th>Gene</th><th>Placebo</th><th>Estrogen</th></tr></thead><tbody><tr><td>5.475</td><td><italic>CCT7</italic></td><td align="char">18.388</td><td align="char">817.972</td></tr><tr><td>4.740</td><td><italic>RPL3</italic></td><td align="char">169.050</td><td align="char">4519.695</td></tr><tr><td>4.437</td><td><italic>APOE</italic></td><td align="char">153.891</td><td align="char">3333.896</td></tr><tr><td>4.377</td><td><italic>EXOSC5</italic></td><td align="char">12.298</td><td align="char">255.57</td></tr><tr><td>4.318</td><td><italic>ANXA2</italic></td><td align="char">22.690</td><td align="char">452.592</td></tr><tr><td>4.098</td><td><italic>OGN</italic></td><td align="char">55.492</td><td align="char">950.043</td></tr><tr><td>4.088</td><td><italic>SLC1A6</italic></td><td align="char">24.018</td><td align="char">408.522</td></tr><tr><td>3.964</td><td><italic>RPL8</italic></td><td align="char">121.042</td><td align="char">1889.565</td></tr><tr><td>3.946</td><td><italic>ARF5</italic></td><td align="char">29.451</td><td align="char">454.037</td></tr><tr><td>3.928</td><td><italic>STOML2</italic></td><td align="char">35.393</td><td align="char">538.624</td></tr><tr><td>3.823</td><td><italic>ZFP91</italic></td><td align="char">72.352</td><td align="char">1024.249</td></tr><tr><td>3.788</td><td><italic>NUDT1</italic></td><td align="char">19.980</td><td align="char">276.067</td></tr><tr><td>3.765</td><td><italic>MPZ</italic></td><td align="char">60.006</td><td align="char">815.877</td></tr><tr><td>3.740</td><td><italic>CRMP1</italic></td><td align="char">80.719</td><td align="char">1079.099</td></tr><tr><td>3.722</td><td><italic>RPS10</italic></td><td align="char">450.882</td><td align="char">5952.8</td></tr></tbody></table><table-wrap-foot><fn><p>NOTE. This table shows the log2 fold change for the top 15 genes, with the highest estrogen-induced fold change in the neurons of estrogen-treated versus placebo-treated ovariectomized female rhesus macaques. There were 15,517 genes in total (The full list is in <xref ref-type="sec" rid="appsec1">Supplementary Table 1</xref>). This table shows that the gene with the highest estrogen-induced expression is the microtubule gene <italic>CCT7</italic>, and it shows <italic>APOE</italic> has the third highest increase in expression with a log2 fold change of 4.44.</p></fn></table-wrap-foot></table-wrap></p>
</sec>
<sec id="sec3.5">
<label>3.5</label>
<title>Progesterone acts antagonistically to estrogen genome-wide</title>
<p id="p0065">HRT often includes a progesterone component, although not much is known about how progesterone influences gene expression in the brain. Interestingly, we found that estrogen downregulates the progesterone receptor (PGR) by nearly 6-fold (<xref ref-type="fig" rid="fig2">Fig. 2</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 1</xref>), and when we compared the expression values of macaques treated with both estrogen and progesterone with macaques treated with estrogen only, we found that adding progesterone antagonized estrogen-induced gene expression on a genome-wide scale (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig3">Fig. 3</xref>). The mean expression of the 504 estrogen upregulated genes nearly halved after adding progesterone (t-test <italic>P</italic> value = 6.968e<sup>−14</sup>), and the mean expression of the estrogen downregulated genes increased by more than two-fold after adding progesterone (t-test <italic>P</italic> value = .001277). We found that progesterone antagonized the expression of <italic>APOE</italic>, other known AD risk genes [<xref ref-type="bibr" rid="bib54">54</xref>] (<xref ref-type="sec" rid="appsec1">Supplementary Material</xref>), the 84 genes intersecting estrogen upregulated and Alzheimer's downregulated gene sets, and mitochondrial [<xref ref-type="bibr" rid="bib49">49</xref>] and synapse genes [<xref ref-type="bibr" rid="bib52">52</xref>,<xref ref-type="bibr" rid="bib53">53</xref>] (<xref ref-type="fig" rid="fig3">Fig. 3</xref>).<fig id="fig2"><label>Fig. 2</label><caption><p>Fold change of estrogen-induced expression in macaque neurons plotted against placebo expression (We only show genes with placebo expression value &lt; 25,000.). Shown in red are genes previously identified through genome-wide association studies to be associated with AD risk [<xref ref-type="bibr" rid="bib54">54</xref>] (<xref ref-type="sec" rid="appsec1">Supplementary Material</xref>). The progesterone receptor (<italic>PGR</italic>) gene is shown in blue. The plot shows <italic>APOE</italic> to have the third highest estrogen-induced fold change and <italic>PGR</italic> to have the fourth largest decrease in expression. It also shows <italic>APP</italic> and <italic>SORL1</italic> to have estrogen-induced log2 fold change of &gt; 2.</p></caption><graphic xlink:href="gr2"></graphic></fig><fig id="fig3"><label>Figure 3</label><caption><p>Antagonistic impact of progesterone in various gene sets. (A) GWAs identified AD risk genes [<xref ref-type="bibr" rid="bib54">54</xref>] (<xref ref-type="sec" rid="appsec1">Supplementary Material</xref>). (B) 84 genes intersecting estrogen upregulated and Alzheimer downregulated. (C) Synapse genes [<xref ref-type="bibr" rid="bib52">52</xref>, <xref ref-type="bibr" rid="bib53">53</xref>]. (D) Mitochondrial genes [<xref ref-type="bibr" rid="bib49">49</xref>].</p></caption><graphic xlink:href="gr3"></graphic></fig></p>
</sec>
<sec id="sec3.6">
<label>3.6</label>
<title>Rare variant burden test on exome sequencing data</title>
<p id="p0070">By linking <italic>APOE</italic>, mitochondrial, and synapse genes to estrogen action in neurons, the macaque experiment provided insight into the mechanism by which estrogen loss at menopause could increase vulnerability to AD in women. To validate our genomic evidence linking menopause to AD risk, we sought to analyze an independent genomic data set. We obtained exome sequencing data from the Alzheimer's disease sequencing project [<xref ref-type="bibr" rid="bib55">55</xref>]. Our aim was to assess whether any differences in mutation patterns in female AD cases compared with female AD controls could link menopause to increased vulnerability to AD in women. To enrich for AD cases with a strong genetic component, we only considered cases with the age of onset &lt;75 years, which left us with a total of 2161 cases and 3657 controls, in which 1208 were female cases and 2162 were female controls.</p>
<p id="p0075">To maximize our chances of uncovering genes that disrupt core biology, we focused on ultra-rare mutations known as singletons (mutations only seen once within the data set). These mutations are likely to exert strong biological effects because they have been kept at low frequency by purifying selection. We applied rigorous filtering on these singletons to enrich for causal mutations, which we defined as loss of function, nonsense-mediated decay, annotated as ‘HIGH’ impact by SNPEff (version 4.3) [<xref ref-type="bibr" rid="bib39">39</xref>] or annotated as both missense and probably damaging by PolyPhen [<xref ref-type="bibr" rid="bib40">40</xref>] (Please see <xref ref-type="sec" rid="appsec1">Supplementary Tables</xref> for mutation coordinates). We developed a rare variant collapsing burden test similar to that applied to copy number variations in autism [<xref ref-type="bibr" rid="bib43">43</xref>] but modified it for deleterious singleton single-nucleotide variants (<xref ref-type="sec" rid="appsec1">Supplementary Table 8</xref>). Currently, many sequencing studies use the optimal test within the family of sequence kernel association tests [<xref ref-type="bibr" rid="bib56">56</xref>,<xref ref-type="bibr" rid="bib57">57</xref>] to identify disease-associated genes; however, we chose to use our rare variant collapsing burden test because simulations have shown that when most variants are likely to be causal, the collapsing burden test outperforms the optimal test within the family of sequence kernel association tests [<xref ref-type="bibr" rid="bib56">56</xref>,<xref ref-type="bibr" rid="bib57">57</xref>].</p>
</sec>
<sec id="sec3.7">
<label>3.7</label>
<title>Validation of our ultra-rare variant association test</title>
<p id="p0080">We first aimed to validate our rare variant burden test by performing it on all AD cases (n = 2161) and all AD controls (n = 3657). When we did this, we found our top hit to be <italic>SORL1</italic> and our third top hit to be <italic>ABCA7</italic> (<xref ref-type="fig" rid="fig4">Fig. 4</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 9</xref>). This finding confirmed the validity of our method because both <italic>SORL1</italic> and <italic>ABCA7</italic> are well-known AD risk loci [<xref ref-type="bibr" rid="bib54">54</xref>,<xref ref-type="bibr" rid="bib58">58</xref>,<xref ref-type="bibr" rid="bib59">59</xref>]. Interestingly, our macaque neuronal gene expression data also identified <italic>SORL1</italic> to be highly regulated by estrogen (<xref ref-type="fig" rid="fig2">Fig. 2</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 1</xref>).</p>
</sec>
<sec id="sec3.8">
<label>3.8</label>
<title>Identification of <italic>MCM8</italic> as a female-specific risk factor</title>
<p id="p0085">To identify female-specific risk factors, we performed our rare variant burden test to compare female AD cases (n = 1208) with female AD controls (n = 2162). We identified 50 genes with both false discovery rate and <italic>P</italic> value &lt; .05 (<xref ref-type="table" rid="tbl2">Table 2</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 10</xref>). Of these 50 genes, 45 contained excess mutations in cases and 5 contained excess mutations in controls. The genes with excess mutations in cases included <italic>MCM8</italic>, which we found to have five missense variants predicted to be damaging by PolyPhen [<xref ref-type="bibr" rid="bib40">40</xref>] (<xref ref-type="sec" rid="appsec1">Supplementary Table 11</xref>, <xref ref-type="fig" rid="fig4">Fig. 4</xref>). This finding provides robust independent support that menopause could underlie AD vulnerability in women because <italic>MCM8</italic> has been strongly associated with primary ovarian insufficiency [<xref ref-type="bibr" rid="bib60">60</xref>] and early menopause in women [<xref ref-type="bibr" rid="bib61">61</xref>]. We also found excess mutations in female AD cases in the <italic>CCT7</italic> and <italic>MCAT</italic> genes; which is interesting because our macaque data reveal <italic>CCT7</italic> to have the highest estrogen-induced fold change in neurons(<xref ref-type="table" rid="tbl1">Table 1</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 1</xref>) and <italic>MCAT</italic> is a mitochondrial enzyme. To identify potential protective factors, we looked for genes with excess mutations in controls and found the brain size gene <italic>ASPM</italic>, which had eight missense variants predicted by PolyPhen to be damaging [<xref ref-type="bibr" rid="bib40">40</xref>] and one stop-gain mutation (<xref ref-type="fig" rid="fig4">Fig. 4</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 12</xref>). We also performed our rare variant burden test on male cases (n = 953) and male controls (n = 1495) (<xref ref-type="sec" rid="appsec1">Supplementary Table 13</xref>) and did not detect statistically significant excess of deleterious singletons in <italic>MCM8</italic>, <italic>ASPM</italic>, <italic>CCT7</italic>, or <italic>MCAT</italic>.<table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Genes with excess deleterious singletons in female cases or female controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene</th><th>FDR</th><th>Cases</th><th>Controls</th><th>Type</th></tr></thead><tbody><tr><td><italic>SORL1</italic></td><td align="char">0</td><td align="char">13</td><td align="char">4</td><td>Excess cases</td></tr><tr><td><italic>DNAH2</italic></td><td align="char">0.002</td><td align="char">11</td><td align="char">3</td><td>Excess cases</td></tr><tr><td><italic>METTL13</italic></td><td align="char">0.002</td><td align="char">6</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>INTS7</italic></td><td align="char">0.003</td><td align="char">7</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>KDM5A</italic></td><td align="char">0.005</td><td align="char">8</td><td align="char">2</td><td>Excess cases</td></tr><tr><td><italic>SMG7</italic></td><td align="char">0.005</td><td align="char">5</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>OBSCN</italic></td><td align="char">0.007</td><td align="char">6</td><td align="char">34</td><td>Excess controls</td></tr><tr><td><italic>ADSSL1</italic></td><td align="char">0.007</td><td align="char">5</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>MCM8</italic></td><td align="char">0.007</td><td align="char">5</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>LCTL</italic></td><td align="char">0.009</td><td align="char">5</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>WDFY4</italic></td><td align="char">0.009</td><td align="char">10</td><td align="char">4</td><td>Excess cases</td></tr><tr><td><italic>KIF20B</italic></td><td align="char">0.009</td><td align="char">6</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>NLRC5</italic></td><td align="char">0.01</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>MUC2</italic></td><td align="char">0.011</td><td align="char">6</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>ZNF780B</italic></td><td align="char">0.011</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>PTPN13</italic></td><td align="char">0.012</td><td align="char">0</td><td align="char">11</td><td>Excess controls</td></tr><tr><td><italic>MCAT</italic></td><td align="char">0.012</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>RPP40</italic></td><td align="char">0.012</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>ABCA7</italic></td><td align="char">0.013</td><td align="char">7</td><td align="char">2</td><td>Excess cases</td></tr><tr><td><italic>CALCR</italic></td><td align="char">0.013</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>CNGA4</italic></td><td align="char">0.013</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>INTU</italic></td><td align="char">0.013</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>BTRC</italic></td><td align="char">0.014</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>PLEKHH3</italic></td><td align="char">0.014</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>ELMSAN1</italic></td><td align="char">0.015</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>ASPM</italic></td><td align="char">0.015</td><td align="char">0</td><td align="char">9</td><td>Excess controls</td></tr><tr><td><italic>TANC2</italic></td><td align="char">0.016</td><td align="char">7</td><td align="char">2</td><td>Excess cases</td></tr><tr><td><italic>PTPRC</italic></td><td align="char">0.016</td><td align="char">5</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>CTH</italic></td><td align="char">0.017</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>SPHK1</italic></td><td align="char">0.017</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>AASDH</italic></td><td align="char">0.019</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>SLC39A4</italic></td><td align="char">0.019</td><td align="char">5</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>NFRKB</italic></td><td align="char">0.019</td><td align="char">6</td><td align="char">2</td><td>Excess cases</td></tr><tr><td><italic>CCT7</italic></td><td align="char">0.02</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>PGBD4</italic></td><td align="char">0.02</td><td align="char">5</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>FGA</italic></td><td align="char">0.021</td><td align="char">4</td><td align="char">0</td><td>Excess cases</td></tr><tr><td><italic>KLHL17</italic></td><td align="char">0.023</td><td align="char">1</td><td align="char">13</td><td>Excess controls</td></tr><tr><td><italic>SCN3A</italic></td><td align="char">0.025</td><td align="char">5</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>RP1L1</italic></td><td align="char">0.027</td><td align="char">6</td><td align="char">2</td><td>Excess cases</td></tr><tr><td><italic>KDM5B</italic></td><td align="char">0.028</td><td align="char">5</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>KCTD19</italic></td><td align="char">0.029</td><td align="char">5</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>KIAA1211</italic></td><td align="char">0.029</td><td align="char">6</td><td align="char">2</td><td>Excess cases</td></tr><tr><td><italic>C7orf57</italic></td><td align="char">0.03</td><td align="char">5</td><td align="char">1</td><td>Excess cases</td></tr><tr><td><italic>FAT4</italic></td><td align="char">0.032</td><td align="char">2</td><td align="char">17</td><td>Excess controls</td></tr><tr><td><italic>IQGAP1</italic></td><td align="char">0.032</td><td align="char">6</td><td align="char">2</td><td>Excess cases</td></tr><tr><td><italic>TTC28</italic></td><td align="char">0.032</td><td align="char">10</td><td align="char">6</td><td>Excess cases</td></tr><tr><td><italic>FBN2</italic></td><td align="char">0.032</td><td align="char">7</td><td align="char">3</td><td>Excess cases</td></tr><tr><td><italic>GOLGB1</italic></td><td align="char">0.033</td><td align="char">7</td><td align="char">3</td><td>Excess cases</td></tr><tr><td><italic>KMT2E</italic></td><td align="char">0.04</td><td align="char">7</td><td align="char">3</td><td>Excess cases</td></tr><tr><td><italic>SIGLEC1</italic></td><td align="char">0.049</td><td align="char">7</td><td align="char">3</td><td>Excess cases</td></tr></tbody></table><table-wrap-foot><fn id="tspara0025"><p>NOTE. This table shows the significant genes identified from the deleterious singletons association test applied to female cases with the age of onset &lt;75 years (n = 1208) versus female controls (n = 2162). The association test is similar to what was applied to copy number variations in autism [<xref ref-type="bibr" rid="bib43">43</xref>] but modified for deleterious singleton SNPs. The FDR was calculated by randomizing the case-control status as described in the study by Pinto et al. [<xref ref-type="bibr" rid="bib43">43</xref>] 1000 times. A total of 50 genes were identified to have both <italic>P</italic> value &lt; .05 and FDR &lt; .05. After ranking by FDR, and then <italic>P</italic> value, the most associated gene is <italic>SORL1</italic>, although <italic>MCM8</italic>, <italic>MCAT</italic>, <italic>ABCA7</italic>, <italic>ASPM</italic>, and <italic>CCT7</italic> genes are also significant. The third and fourth columns show how many deleterious singletons were identified in female cases and female controls. The fifth column highlights whether the gene had excess mutations in female cases or female controls. A total of 45 genes had excess mutations in female cases, and five genes had excess mutations in female controls. <italic>ASPM</italic> is an example of a gene with excess mutations in female controls (Please see <xref ref-type="sec" rid="appsec1">Supplementary Tables</xref> for mutation coordinates).</p></fn><fn id="tspara0030"><p>Abbreviations: SNP, single-nucleotide polymorphism; FDR, false discovery rate.</p></fn></table-wrap-foot></table-wrap><fig id="fig4"><label>Fig. 4</label><caption><p>Deleterious singletons identified in <italic>SORL1</italic>, <italic>ABCA7</italic>, <italic>MCM8</italic>, and <italic>ASPM</italic>. (Genes are not drawn to scale.) We developed a rare variant collapsing burden test similar to what was applied to copy number variations in autism [<xref ref-type="bibr" rid="bib43">43</xref>] but modified for deleterious singleton SNPs. We compared female cases (n = 1208) with female controls (n = 2162) and compared total cases (n = 2161) with total controls (n = 3657). The genes depicted above have both FDR &lt; .05 and <italic>P</italic> value &lt; .05. Abbreviations: SNPs, single-nucleotide polymorphism; FDR, false discovery rate. (Please see <xref ref-type="sec" rid="appsec1">Supplementary Tables</xref> for mutation coordinates).</p></caption><graphic xlink:href="gr4"></graphic></fig></p>
</sec>
</sec>
<sec id="sec4">
<label>4</label>
<title>Discussion</title>
<p id="p0090">Here, we use a unique genomic approach to uncover evidence consistent with estrogen loss at menopause underlying increased vulnerability to AD in women. We link estrogen to mitochondrial and synapse function and demonstrate that estrogen upregulates <italic>APOE</italic> and show that progesterone acts antagonistically to estrogen genome-wide. Finally, we use an independent exome sequencing data set to demonstrate that female AD cases have excess rare, deleterious mutations in the early menopause gene <italic>MCM8</italic>.</p>
<p id="p0095">AD is a disorder of the synapse [<xref ref-type="bibr" rid="bib50">50</xref>,<xref ref-type="bibr" rid="bib51">51</xref>]. In fact, cognitive decline has been shown to correlate most closely with synapse loss [<xref ref-type="bibr" rid="bib51">51</xref>]. Our finding that estrogen upregulates synapse genes fits with those of prior imaging studies, which reveal that hippocampal size correlates with estrogen levels throughout the menstrual cycle [<xref ref-type="bibr" rid="bib62">62</xref>,<xref ref-type="bibr" rid="bib63">63</xref>]. Our data also reveal a central role for mitochondria. We show that estrogen upregulates mitochondrial genes, and our exome data reveal excess mutations in the mitochondrial enzyme <italic>MCAT</italic> (<xref ref-type="table" rid="tbl2">Table 2</xref>), which is also associated with the reduction of amyloid β production [<xref ref-type="bibr" rid="bib64">64</xref>]. These findings are consistent with the bioenergetic state transition hypothesis [<xref ref-type="bibr" rid="bib31">[31]</xref>, <xref ref-type="bibr" rid="bib32">[32]</xref>, <xref ref-type="bibr" rid="bib33">[33]</xref>], which links metabolism deficits in the brains of postmenopausal women [<xref ref-type="bibr" rid="bib31">31</xref>]. Importantly, our data also reveal a convergence of mitochondrial and synapse genes, which is consistent with the notion that mitochondria could influence synapse growth [<xref ref-type="bibr" rid="bib65">65</xref>], possibly to help meet synaptic ATP requirements [<xref ref-type="bibr" rid="bib66">66</xref>].</p>
<p id="p0100">One of the strengths of our study is that we reveal the target genes of estrogen and progesterone action within neurons. These data reveal both <italic>APOE</italic> and <italic>SORL1</italic> to be highly estrogen responsive (<xref ref-type="fig" rid="fig2">Fig. 2</xref>) and, curiously, both <italic>APOE</italic> and <italic>SORL1</italic> are associated with female-specific risk for AD [<xref ref-type="bibr" rid="bib5">[5]</xref>, <xref ref-type="bibr" rid="bib6">[6]</xref>, <xref ref-type="bibr" rid="bib7">[7]</xref>,<xref ref-type="bibr" rid="bib67">67</xref>]—suggesting that estrogen may interact with genetic mutations to confer sex-biased risk.</p>
<p id="p0105">We used genomic data spanning multiple data types to cross validate our findings on estrogen loss and AD risk. We found excess deleterious singleton mutations in the ovarian failure [<xref ref-type="bibr" rid="bib60">60</xref>,<xref ref-type="bibr" rid="bib68">[68]</xref>, <xref ref-type="bibr" rid="bib69">[69]</xref>, <xref ref-type="bibr" rid="bib70">[70]</xref>, <xref ref-type="bibr" rid="bib71">[71]</xref>] and early menopause [<xref ref-type="bibr" rid="bib61">61</xref>,<xref ref-type="bibr" rid="bib72">[72]</xref>, <xref ref-type="bibr" rid="bib73">[73]</xref>, <xref ref-type="bibr" rid="bib74">[74]</xref>, <xref ref-type="bibr" rid="bib75">[75]</xref>, <xref ref-type="bibr" rid="bib76">[76]</xref>] gene <italic>MCM8</italic> (<xref ref-type="table" rid="tbl2">Table 2</xref>, <xref ref-type="sec" rid="appsec1">Supplementary Table 11</xref>), providing robust support for our hypothesis that estrogen loss at menopause confers increased vulnerability to AD in women. This finding fits with previous studies that have linked surgical menopause to doubled lifetime risk for dementia [<xref ref-type="bibr" rid="bib23">23</xref>], increased risk for AD neuropathology [<xref ref-type="bibr" rid="bib22">22</xref>] and cognitive decline [<xref ref-type="bibr" rid="bib22">22</xref>].</p>
<p id="p0110">Our method also provided the opportunity to identify potential protective genetic factors. Our finding of excess rare, deleterious singletons in the brain size gene <italic>ASPM</italic> [<xref ref-type="bibr" rid="bib77">77</xref>] (<xref ref-type="sec" rid="appsec1">Supplementary Tables 10,12</xref>) is interesting because <italic>ASPM</italic> has also been linked to the human-specific evolution of brain size [<xref ref-type="bibr" rid="bib78">78</xref>,<xref ref-type="bibr" rid="bib79">79</xref>] and because <italic>ASPM</italic> may represent a neural substrate [<xref ref-type="bibr" rid="bib80">80</xref>] for the “brain reserve” hypothesis [<xref ref-type="bibr" rid="bib81">[81]</xref>, <xref ref-type="bibr" rid="bib82">[82]</xref>, <xref ref-type="bibr" rid="bib83">[83]</xref>, <xref ref-type="bibr" rid="bib84">[84]</xref>], which reasons that large brain size can protect against cognitive decline [<xref ref-type="bibr" rid="bib83">83</xref>].</p>
<p id="p0115">Our finding that progesterone acts antagonistically to estrogen genome-wide is particularly provocative. Cell culture studies have suggested progesterone to be antagonistic [<xref ref-type="bibr" rid="bib85">[85]</xref>, <xref ref-type="bibr" rid="bib86">[86]</xref>, <xref ref-type="bibr" rid="bib87">[87]</xref>], but our data highlight that the antagonism may be genome-wide. The seemingly contradictory findings from longitudinal studies of HRT use may be resolved by the consideration that progesterone acts antagonistically to estrogen. For instance, a large Finnish study of 230,580 women [<xref ref-type="bibr" rid="bib88">88</xref>] found HRT containing both estrogen and progesterone seemed to increase risk for dementia, whereas estrogen-only HRT reduced the risk. This is consistent with the recent analyses [<xref ref-type="bibr" rid="bib89">89</xref>] of two clinical trials, the Kronos Early Estrogen Prevention Study–Cognitive and Affective Study (KEEPS-Cogs) and the Early <italic>vs</italic>. Late Intervention Trial with Estradiol-Cognitive Endpoints (ELITE-Cog) [<xref ref-type="bibr" rid="bib89">89</xref>], which found that taking HRT between the ages of 50 and 54 years is not cognitively detrimental, whereas taking HRT between the ages of 65 and 79 years was associated with reductions in global cognition, working memory, and executive function [<xref ref-type="bibr" rid="bib89">89</xref>].</p>
<sec id="sec4.1">
<label>4.1</label>
<title>Limitations</title>
<p id="p0120">Our data are valuable for gaining much needed clarity on the role of estrogen in AD risk; however, there are some limitations. First, we relied on macaque gene expression data to understand estrogen response in the human brain—human data would have been better, but no such datasets exist, and the experiments required to get such datasets mean they are unlikely to exist in the future. Macaques are preferable [<xref ref-type="bibr" rid="bib90">90</xref>] to rodents because nonhuman primates more accurately recapitulate AD-relevant gene expression in the human brain [<xref ref-type="bibr" rid="bib91">91</xref>]. Another potential limitation is the limited sample size of each treatment, which is why we focused on fold change, as other statistical tests were not feasible. However, although our sample size may be limiting, the <italic>APOE</italic> gene signal was captured by three probes, and the data were obtained from laser-captured neurons, so are unlikely to be confounded by expression from other cell types. Another potential limitation could be the different sample sizes in the exome data for men compared with women, which may lead to differential power to detect. We focused our analysis on females, which actually had more samples than males, however, not finding an association in males, may be due to decreased power to detect rather than an actual biological difference.</p>
</sec>
<sec id="sec4.2">
<label>4.2</label>
<title>Future work</title>
<p id="p0125">Our study is timely as it fits well with recent reports that have linked longer reproductive periods and more months being pregnant with reduced risk for AD [<xref ref-type="bibr" rid="bib89">89</xref>]. Future work in this field may include stratifying female samples by HRT use to quantify the proportion of risk attributed to genetic mutations versus loss of estrogen and performing genome-wide association studies to uncover any association between common variants in <italic>MCM8</italic> and AD risk in women.</p>
</sec>
<sec id="sec4.3">
<label>4.3</label>
<title>Conclusions</title>
<p id="p0130">Here, we endeavored to use genomic data to address the knowledge gaps surrounding why women have increased risk for AD, and in doing so, we address the controversy initiated by the Women's Health Initiative Memory Study [<xref ref-type="bibr" rid="bib29">29</xref>,<xref ref-type="bibr" rid="bib30">30</xref>]. Our comprehensive, integrative, genomic analyses lead us to conclude that estrogen loss is likely to contribute to AD vulnerability—suggesting that increased risk for AD in women may be attributed to menopause.<boxed-text id="dtbox1"><caption><title>Research in context</title></caption><p id="p0135"><list id="olist0010" list-type="simple"><list-item id="o0010"><label>1.</label><p id="p0140">Systematic review: We searched the literature, recent conference abstracts, YouTube, and review papers by the think tank convened by the Women's Alzheimer's Research Initiative and the Society for Women's Health Research Interdisciplinary Network on Alzheimer's disease (AD) to evaluate the accumulated knowledge related to whether estrogen loss contributes to AD risk in women.</p></list-item><list-item id="o0015"><label>2.</label><p id="p0145">Interpretation: Previous findings have been based on observational and randomized control studies. We took a different approach of gene expression and genetic mutation data. Our findings provide quantitative evidence for the role of estrogen in AD risk, with particular emphasis on mitochondrial function.</p></list-item><list-item id="o0020"><label>3.</label><p id="p0150">Future directions: Future work can involve stratifying women by HRT use to determine whether the genetic signal is stronger in women without HRT and performing genome-wide association studies to see if common variants in <italic>MCM8</italic> confer increased risk for AD.</p></list-item></list></p></boxed-text></p>
</sec>
</sec>
</body>
<back>
<ref-list id="cebib0010">
<title>References</title>
<ref id="bib1">
<label>1</label>
<element-citation id="sref1" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Launer</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Dewey</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Letenneur</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ott</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group</article-title>
<source/>Neurology
          <volume>53</volume>
<year>1999</year>
<fpage>1992</fpage>
<lpage>1997</lpage>
<pub-id pub-id-type="pmid">10599770</pub-id>
</element-citation>
</ref>
<ref id="bib2">
<label>2</label>
<element-citation id="sref2" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hebert</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Weuve</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scherr</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Alzheimer disease in the United States (2010-2050) estimated using the 2010 census</article-title>
<source/>Neurology
          <volume>80</volume>
<year>2013</year>
<fpage>1778</fpage>
<lpage>1783</lpage>
<pub-id pub-id-type="pmid">23390181</pub-id>
</element-citation>
</ref>
<ref id="bib3">
<label>3</label>
<element-citation id="sref3" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seshadri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Beiser</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Au</surname>
<given-names>R</given-names>
</name>
<name>
<surname>McNulty</surname>
<given-names>K</given-names>
</name>
<name>
<surname>White</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Lifetime risk of dementia and Alzheimer’s disease. The impact of mortality on risk estimates in the Framingham Study</article-title>
<source/>Neurology
          <volume>49</volume>
<year>1997</year>
<fpage>1498</fpage>
<lpage>1504</lpage>
<pub-id pub-id-type="pmid">9409336</pub-id>
</element-citation>
</ref>
<ref id="bib4">
<label>4</label>
<element-citation id="sref4" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strittmatter</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Schmechel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Enghild</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Salvesen</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease</article-title>
<source/>Proc Natl Acad Sci U S A
          <volume>90</volume>
<year>1993</year>
<fpage>1977</fpage>
<lpage>1981</lpage>
<pub-id pub-id-type="pmid">8446617</pub-id>
</element-citation>
</ref>
<ref id="bib5">
<label>5</label>
<element-citation id="sref6" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farrer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cupples</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kukull</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mayeux</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Effects of Age, Sex, and Ethnicity on the Association between Apolipoprotein E Genotype and Alzheimer Disease</article-title>
<source/>JAMA
          <volume>278</volume>
<year>1997</year>
<fpage>1349</fpage>
<lpage>1356</lpage>
<pub-id pub-id-type="pmid">9343467</pub-id>
</element-citation>
</ref>
<ref id="bib6">
<label>6</label>
<element-citation id="sref7" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>PM</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Buckwaiter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Seeman</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Poirier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</name>
</person-group>
<article-title>Evidence for an interaction between apolipoprotein E genotype, gender and Alzheimer disease</article-title>
<source/>Alzheimer Dis Assoc Disord
          <volume>13</volume>
<year>1999</year>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">10609670</pub-id>
</element-citation>
</ref>
<ref id="bib7">
<label>7</label>
<element-citation id="sref8" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Payami</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zareparsi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Montee</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Sexton</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Kaye</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women</article-title>
<source/>Am J Hum Genet
          <volume>58</volume>
<year>1996</year>
<fpage>803</fpage>
<lpage>811</lpage>
<pub-id pub-id-type="pmid">8644745</pub-id>
</element-citation>
</ref>
<ref id="bib8">
<label>8</label>
<element-citation id="sref9" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nebel</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kantarci</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Understanding the impact of sex and gender in Alzheimer’s disease: A call to action</article-title>
<source/>Alzheimers Dement
          <volume>14</volume>
<year>2018</year>
<fpage>1171</fpage>
<lpage>1183</lpage>
<pub-id pub-id-type="pmid">29907423</pub-id>
</element-citation>
</ref>
<ref id="bib9">
<label>9</label>
<element-citation id="sref10" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snyder</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Asthana</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bain</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Brinton</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Craft</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dubal</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Sex biology contributions to vulnerability to Alzheimer’s disease: A think tank convened by the Women’s Alzheimer’s Research Initiative</article-title>
<source/>Alzheimers Dement
          <volume>12</volume>
<year>2016</year>
<fpage>1186</fpage>
<lpage>1196</lpage>
<pub-id pub-id-type="pmid">27692800</pub-id>
</element-citation>
</ref>
<ref id="bib10">
<label>10</label>
<element-citation id="sref11" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waring</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rocca</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tangalos</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kokmen</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Postmenopausal estrogen replacement therapy and risk of AD: a population-based study</article-title>
<source/>Neurology
          <volume>52</volume>
<year>1999</year>
<fpage>965</fpage>
<lpage>970</lpage>
<pub-id pub-id-type="pmid">10102413</pub-id>
</element-citation>
</ref>
<ref id="bib11">
<label>11</label>
<element-citation id="sref12" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zandi</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Plassman</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Welsh-Bohmer</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Steffens</surname>
<given-names>DC</given-names>
</name>
</person-group>
<article-title>Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study</article-title>
<source/>JAMA
          <volume>288</volume>
<year>2002</year>
<fpage>2123</fpage>
<lpage>2129</lpage>
<pub-id pub-id-type="pmid">12413371</pub-id>
</element-citation>
</ref>
<ref id="bib12">
<label>12</label>
<element-citation id="sref13" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paganini-Hill</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>V.W.</given-names>
</name>
</person-group>
<article-title>Estrogen replacement therapy and risk of Alzheimer disease</article-title>
<source/>Arch Intern Med
          <volume>156</volume>
<year>1996</year>
<fpage>2213</fpage>
<lpage>2217</lpage>
<pub-id pub-id-type="pmid">8885820</pub-id>
</element-citation>
</ref>
<ref id="bib13">
<label>13</label>
<element-citation id="sref14" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McEwen</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Woolley</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain</article-title>
<source/>Exp Gerontol
          <volume>29</volume>
<year>1994</year>
<fpage>431</fpage>
<lpage>436</lpage>
<pub-id pub-id-type="pmid">7925761</pub-id>
</element-citation>
</ref>
<ref id="bib14">
<label>14</label>
<element-citation id="sref15" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woolley</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Gould</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Frankfurt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons</article-title>
<source/>J Neurosci
          <volume>10</volume>
<year>1990</year>
<fpage>4035</fpage>
<lpage>4039</lpage>
<pub-id pub-id-type="pmid">2269895</pub-id>
</element-citation>
</ref>
<ref id="bib15">
<label>15</label>
<element-citation id="sref16" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woolley</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>B.S.</given-names>
</name>
</person-group>
<article-title>Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat</article-title>
<source/>J Neurosci
          <volume>12</volume>
<year>1992</year>
<fpage>2549</fpage>
<lpage>2554</lpage>
<pub-id pub-id-type="pmid">1613547</pub-id>
</element-citation>
</ref>
<ref id="bib16">
<label>16</label>
<element-citation id="sref17" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gould</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Woolley</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Frankfurt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood</article-title>
<source/>J Neurosci
          <volume>10</volume>
<year>1990</year>
<fpage>1286</fpage>
<lpage>1291</lpage>
<pub-id pub-id-type="pmid">2329377</pub-id>
</element-citation>
</ref>
<ref id="bib17">
<label>17</label>
<element-citation id="sref18" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galea</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Spritzer</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Pawluski</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Gonadal hormone modulation of hippocampal neurogenesis in the adult</article-title>
<source/>Hippocampus
          <volume>16</volume>
<year>2006</year>
<fpage>225</fpage>
<lpage>232</lpage>
<pub-id pub-id-type="pmid">16411182</pub-id>
</element-citation>
</ref>
<ref id="bib18">
<label>18</label>
<element-citation id="sref19" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inagaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Frankfurt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luine</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Estrogen-induced memory enhancements are blocked by acute bisphenol A in adult female rats: role of dendritic spines</article-title>
<source/>Endocrinology
          <volume>153</volume>
<year>2012</year>
<fpage>3357</fpage>
<lpage>3367</lpage>
<pub-id pub-id-type="pmid">22569790</pub-id>
</element-citation>
</ref>
<ref id="bib19">
<label>19</label>
<element-citation id="sref20" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guerra</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hernandez-Jimenez</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor</article-title>
<source/>Neuroscience
          <volume>121</volume>
<year>2003</year>
<fpage>917</fpage>
<lpage>926</lpage>
<pub-id pub-id-type="pmid">14580942</pub-id>
</element-citation>
</ref>
<ref id="bib20">
<label>20</label>
<element-citation id="sref21" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilsen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brinton</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function</article-title>
<source/>BMC Neurosci
          <volume>7</volume>
<year>2006</year>
<fpage>74</fpage>
<pub-id pub-id-type="pmid">17083736</pub-id>
</element-citation>
</ref>
<ref id="bib21">
<label>21</label>
<element-citation id="sref22" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lancaster</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Honda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Staufenbiel</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer’s disease animal model</article-title>
<source/>Proc Natl Acad Sci U S A
          <volume>102</volume>
<year>2005</year>
<fpage>19198</fpage>
<lpage>19203</lpage>
<pub-id pub-id-type="pmid">16365303</pub-id>
</element-citation>
</ref>
<ref id="bib22">
<label>22</label>
<element-citation id="sref23" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bove</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Secor</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chibnik</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women</article-title>
<source/>Neurology
          <volume>82</volume>
<year>2014</year>
<fpage>222</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="pmid">24336141</pub-id>
</element-citation>
</ref>
<ref id="bib23">
<label>23</label>
<element-citation id="sref24" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rocca</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Bower</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Maraganore</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Ahlskog</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Grossardt</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>de Andrade</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause</article-title>
<source/>Neurology
          <volume>69</volume>
<year>2007</year>
<fpage>1074</fpage>
<lpage>1083</lpage>
<pub-id pub-id-type="pmid">17761551</pub-id>
</element-citation>
</ref>
<ref id="bib24">
<label>24</label>
<element-citation id="sref25" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Brinton</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Gore</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women</article-title>
<source/>J Neurosci
          <volume>26</volume>
<year>2006</year>
<fpage>10332</fpage>
<lpage>10348</lpage>
<pub-id pub-id-type="pmid">17035515</pub-id>
</element-citation>
</ref>
<ref id="bib25">
<label>25</label>
<element-citation id="sref26" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeBlanc</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Janowsky</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>HD</given-names>
</name>
</person-group>
<article-title>Hormone replacement therapy and cognition: systematic review and meta-analysis</article-title>
<source/>JAMA
          <volume>285</volume>
<year>2001</year>
<fpage>1489</fpage>
<lpage>1499</lpage>
<pub-id pub-id-type="pmid">11255426</pub-id>
</element-citation>
</ref>
<ref id="bib26">
<label>26</label>
<element-citation id="sref27" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henderson</surname>
<given-names>VW</given-names>
</name>
<name>
<surname>Benke</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Cupples</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Farrer</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Group</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age</article-title>
<source/>J Neurol Neurosurg Psychiatry
          <volume>76</volume>
<year>2005</year>
<fpage>103</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">15608005</pub-id>
</element-citation>
</ref>
<ref id="bib27">
<label>27</label>
<element-citation id="sref28" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitmer</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Quesenberry</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yaffe</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Timing of hormone therapy and dementia: the critical window theory revisited</article-title>
<source/>Ann Neurol
          <volume>69</volume>
<year>2011</year>
<fpage>163</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="pmid">21280086</pub-id>
</element-citation>
</ref>
<ref id="bib28">
<label>28</label>
<element-citation id="sref29" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Breitner</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Whitmer</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hayden</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wengreen</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study</article-title>
<source/>Neurology
          <volume>79</volume>
<year>2012</year>
<fpage>1846</fpage>
<lpage>1852</lpage>
<pub-id pub-id-type="pmid">23100399</pub-id>
</element-citation>
</ref>
<ref id="bib29">
<label>29</label>
<element-citation id="sref30" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shumaker</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Legault</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kuller</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rapp</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Thal</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study</article-title>
<source/>JAMA
          <volume>291</volume>
<year>2004</year>
<fpage>2947</fpage>
<lpage>2958</lpage>
<pub-id pub-id-type="pmid">15213206</pub-id>
</element-citation>
</ref>
<ref id="bib30">
<label>30</label>
<element-citation id="sref31" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Craig</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Maki</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>The Women's Health Initiative Memory Study: findings and implications for treatment</article-title>
<source/>Lancet Neurol
          <volume>4</volume>
<year>2005</year>
<fpage>190</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="pmid">15721829</pub-id>
</element-citation>
</ref>
<ref id="bib31">
<label>31</label>
<element-citation id="sref32" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mosconi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Berti</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Guyara-Quinn</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McHugh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Petrongolo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Osorio</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery</article-title>
<source/>PLoS One
          <volume>12</volume>
<year>2017</year>
<fpage>e0185926</fpage>
<pub-id pub-id-type="pmid">29016679</pub-id>
</element-citation>
</ref>
<ref id="bib32">
<label>32</label>
<element-citation id="sref33" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brinton</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Cadenas</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Perimenopause as a neurological transition state</article-title>
<source/>Nat Rev Endocrinol
          <volume>11</volume>
<year>2015</year>
<fpage>393</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">26007613</pub-id>
</element-citation>
</ref>
<ref id="bib33">
<label>33</label>
<element-citation id="sref34" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rettberg</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brinton</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Estrogen: a master regulator of bioenergetic systems in the brain and body</article-title>
<source/>Front Neuroendocrinol
          <volume>35</volume>
<year>2014</year>
<fpage>8</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">23994581</pub-id>
</element-citation>
</ref>
<ref id="bib34">
<label>34</label>
<element-citation id="sref35" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brinton</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications</article-title>
<source/>Trends Neurosci
          <volume>31</volume>
<year>2008</year>
<fpage>529</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="pmid">18774188</pub-id>
</element-citation>
</ref>
<ref id="bib35">
<label>35</label>
<element-citation id="sref36" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Cadenas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brinton</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence</article-title>
<source/>Biochim Biophys Acta
          <volume>1800</volume>
<year>2010</year>
<fpage>1121</fpage>
<lpage>1126</lpage>
<pub-id pub-id-type="pmid">20538040</pub-id>
</element-citation>
</ref>
<ref id="bib36">
<label>36</label>
<element-citation id="sref37" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mosconi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Berti</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McHugh</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Petrongolo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Varsavsky</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging</article-title>
<source/>Neurology
          <volume>89</volume>
<year>2017</year>
<fpage>1382</fpage>
<lpage>1390</lpage>
<pub-id pub-id-type="pmid">28855400</pub-id>
</element-citation>
</ref>
<ref id="bib37">
<label>37</label>
<element-citation id="sref38" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Brinton</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Estrogen regulation of mitochondrial respiration is cell type and er subtype specific</article-title>
<source/>Alzheimer's Demen
          <volume>13</volume>
<year>2017</year>
</element-citation>
</ref>
<ref id="bib38">
<label>38</label>
<element-citation id="sref39" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Domrachev</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lash</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title>
<source/>Nucleic Acids Res
          <volume>30</volume>
<year>2002</year>
<fpage>207</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="pmid">11752295</pub-id>
</element-citation>
</ref>
<ref id="bib39">
<label>39</label>
<element-citation id="sref40" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cingolani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Platts</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang le</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3</article-title>
<source/>Fly (Austin)
          <volume>6</volume>
<year>2012</year>
<fpage>80</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="pmid">22728672</pub-id>
</element-citation>
</ref>
<ref id="bib40">
<label>40</label>
<element-citation id="sref41" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Sunyaev</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Predicting functional effect of human missense mutations using PolyPhen-2</article-title>
<source/>Curr Protoc Hum Genet
          <year>2013</year>
<comment>Chapter 7:Unit7.20</comment>
</element-citation>
</ref>
<ref id="bib41">
<label>41</label>
<element-citation id="sref42" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genomes Project</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Auton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Garrison</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>HM</given-names>
</name>
</person-group>
<article-title>A global reference for human genetic variation</article-title>
<source/>Nature
          <volume>526</volume>
<year>2015</year>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">26432245</pub-id>
</element-citation>
</ref>
<ref id="bib42">
<label>42</label>
<element-citation id="sref43" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Minikel</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature
          <volume>536</volume>
<year>2016</year>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="bib43">
<label>43</label>
<element-citation id="sref44" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>
<source/>Nature
          <volume>466</volume>
<year>2010</year>
<fpage>368</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="pmid">20531469</pub-id>
</element-citation>
</ref>
<ref id="bib44">
<label>44</label>
<element-citation id="sref45" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bellino</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Wise</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>Nonhuman primate models of menopause workshop</article-title>
<source/>Biol Reprod
          <volume>68</volume>
<year>2003</year>
<fpage>10</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">12493689</pub-id>
</element-citation>
</ref>
<ref id="bib45">
<label>45</label>
<mixed-citation id="sref46" publication-type="other">MSigDB.</mixed-citation>
</ref>
<ref id="bib46">
<label>46</label>
<element-citation id="sref47" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mootha</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>
<source/>Proc Natl Acad Sci U S A
          <volume>102</volume>
<year>2005</year>
<fpage>15545</fpage>
<lpage>15550</lpage>
<pub-id pub-id-type="pmid">16199517</pub-id>
</element-citation>
</ref>
<ref id="bib47">
<label>47</label>
<element-citation id="sref48" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liberzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Birger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Thorvaldsdottir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ghandi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mesirov</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The Molecular Signatures Database (MSigDB) hallmark gene set collection</article-title>
<source/>Cell Syst
          <volume>1</volume>
<year>2015</year>
<fpage>417</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="pmid">26771021</pub-id>
</element-citation>
</ref>
<ref id="bib48">
<label>48</label>
<element-citation id="sref49" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blalock</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Geddes</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Markesbery</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Landfield</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses</article-title>
<source/>Proc Natl Acad Sci U S A
          <volume>101</volume>
<year>2004</year>
<fpage>2173</fpage>
<lpage>2178</lpage>
<pub-id pub-id-type="pmid">14769913</pub-id>
</element-citation>
</ref>
<ref id="bib49">
<label>49</label>
<element-citation id="sref51" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calvo</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Clauser</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Mootha</surname>
<given-names>V.K.</given-names>
</name>
</person-group>
<article-title>MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins</article-title>
<source/>Nucleic Acids Res
          <volume>44</volume>
<year>2016</year>
<fpage>D1251</fpage>
<lpage>D1257</lpage>
<pub-id pub-id-type="pmid">26450961</pub-id>
</element-citation>
</ref>
<ref id="bib50">
<label>50</label>
<element-citation id="sref52" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koffie</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Spires-Jones</surname>
<given-names>T.L.</given-names>
</name>
</person-group>
<article-title>Alzheimer's disease: synapses gone cold</article-title>
<source/>Mol Neurodegener
          <volume>6</volume>
<year>2011</year>
<fpage>63</fpage>
<pub-id pub-id-type="pmid">21871088</pub-id>
</element-citation>
</ref>
<ref id="bib51">
<label>51</label>
<element-citation id="sref53" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Molina-Porcel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Corrada</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Raible</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>VM</given-names>
</name>
</person-group>
<article-title>Perforant path synaptic loss correlates with cognitive impairment and Alzheimer’s disease in the oldest-old</article-title>
<source/>Brain
          <volume>137</volume>
<year>2014</year>
<fpage>2578</fpage>
<lpage>2587</lpage>
<pub-id pub-id-type="pmid">25012223</pub-id>
</element-citation>
</ref>
<ref id="bib52">
<label>52</label>
<element-citation id="sref54" publication-type="other">
<article-title>Synaptomedb</article-title>
<ext-link ext-link-type="uri" id="intref0015" xlink:href="http://metamoodics.org/SynaptomeDB/index.php">http://metamoodics.org/SynaptomeDB/index.php</ext-link>
</element-citation>
</ref>
<ref id="bib53">
<label>53</label>
<element-citation id="sref55" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirooznia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Avramopoulos</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Valle</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>SynaptomeDB: an ontology-based knowledgebase for synaptic genes</article-title>
<source/>Bioinformatics
          <volume>28</volume>
<year>2012</year>
<fpage>897</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="pmid">22285564</pub-id>
</element-citation>
</ref>
<ref id="bib54">
<label>54</label>
<element-citation id="sref56" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambert</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ibrahim-Verbaas</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Harold</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Naj</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bellenguez</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease</article-title>
<source/>Nat Genet
          <volume>45</volume>
<year>2013</year>
<fpage>1452</fpage>
<lpage>1458</lpage>
<pub-id pub-id-type="pmid">24162737</pub-id>
</element-citation>
</ref>
<ref id="bib55">
<label>55</label>
<element-citation id="sref57" publication-type="other">
<article-title>Alzheimer's Disease Sequencing Project (ADSP)</article-title>
<ext-link ext-link-type="uri" id="intref0020" xlink:href="https://www.niagads.org/adsp/content/about">https://www.niagads.org/adsp/content/about</ext-link>
</element-citation>
</ref>
<ref id="bib56">
<label>56</label>
<element-citation id="sref58" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Optimal tests for rare variant effects in sequencing association studies</article-title>
<source/>Biostatistics
          <volume>13</volume>
<year>2012</year>
<fpage>762</fpage>
<lpage>775</lpage>
<pub-id pub-id-type="pmid">22699862</pub-id>
</element-citation>
</ref>
<ref id="bib57">
<label>57</label>
<element-citation id="sref59" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Boehnke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Rare-variant association testing for sequencing data with the sequence kernel association test</article-title>
<source/>Am J Hum Genet
          <volume>89</volume>
<year>2011</year>
<fpage>82</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">21737059</pub-id>
</element-citation>
</ref>
<ref id="bib58">
<label>58</label>
<element-citation id="sref60" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vardarajan</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Ghani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sheikh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barral</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Rare coding mutations identified by sequencing of Alzheimer disease genome-wide association studies loci</article-title>
<source/>Ann Neurol
          <volume>78</volume>
<year>2015</year>
<fpage>487</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">26101835</pub-id>
</element-citation>
</ref>
<ref id="bib59">
<label>59</label>
<element-citation id="sref61" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Guennec</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Quenez</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Charbonnier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wallon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bellenguez</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>ABCA7 rare variants and Alzheimer disease risk</article-title>
<source/>Neurology
          <volume>86</volume>
<year>2016</year>
<fpage>2134</fpage>
<lpage>2137</lpage>
<pub-id pub-id-type="pmid">27037229</pub-id>
</element-citation>
</ref>
<ref id="bib60">
<label>60</label>
<element-citation id="sref62" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wood-Trageser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chipkin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bachelot</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency</article-title>
<source/>J Clin Endocrinol Metab
          <volume>102</volume>
<year>2017</year>
<fpage>576</fpage>
<lpage>582</lpage>
<pub-id pub-id-type="pmid">27802094</pub-id>
</element-citation>
</ref>
<ref id="bib61">
<label>61</label>
<element-citation id="sref63" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buring</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Pare</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hankinson</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Genome-wide association studies identify loci associated with age at menarche and age at natural menopause</article-title>
<source/>Nat Genet
          <volume>41</volume>
<year>2009</year>
<fpage>724</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="pmid">19448621</pub-id>
</element-citation>
</ref>
<ref id="bib62">
<label>62</label>
<element-citation id="sref64" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Protopopescu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Root</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Altemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Polanecsky</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Hippocampal structural changes across the menstrual cycle</article-title>
<source/>Hippocampus
          <volume>18</volume>
<year>2008</year>
<fpage>985</fpage>
<lpage>988</lpage>
<pub-id pub-id-type="pmid">18767068</pub-id>
</element-citation>
</ref>
<ref id="bib63">
<label>63</label>
<element-citation id="sref65" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barth</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Steele</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rekkas</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Arelin</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pampel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>In-vivo Dynamics of the Human Hippocampus across the Menstrual Cycle</article-title>
<source/>Sci Rep
          <volume>6</volume>
<year>2016</year>
<fpage>32833</fpage>
<pub-id pub-id-type="pmid">27713470</pub-id>
</element-citation>
</ref>
<ref id="bib64">
<label>64</label>
<element-citation id="sref66" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Manczak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Calkins</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Truong</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Mitochondria-targeted catalase reduces abnormal APP processing, amyloid beta production and BACE1 in a mouse model of Alzheimer’s disease: implications for neuroprotection and lifespan extension</article-title>
<source/>Hum Mol Genet
          <volume>21</volume>
<year>2012</year>
<fpage>2973</fpage>
<lpage>2990</lpage>
<pub-id pub-id-type="pmid">22492996</pub-id>
</element-citation>
</ref>
<ref id="bib65">
<label>65</label>
<element-citation id="sref67" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sancheti</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Melcangi</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity</article-title>
<source/>Neurobiol Aging
          <volume>36</volume>
<year>2015</year>
<fpage>2282</fpage>
<lpage>2295</lpage>
<pub-id pub-id-type="pmid">25921624</pub-id>
</element-citation>
</ref>
<ref id="bib66">
<label>66</label>
<element-citation id="sref68" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Jolivet</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Attwell</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Synaptic energy use and supply</article-title>
<source/>Neuron
          <volume>75</volume>
<year>2012</year>
<fpage>762</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="pmid">22958818</pub-id>
</element-citation>
</ref>
<ref id="bib67">
<label>67</label>
<element-citation id="sref69" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cellini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tedde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bagnoli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pradella</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Piacentini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sorbi</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Implication of sex and SORL1 variants in italian patients with Alzheimer disease</article-title>
<source/>Arch Neurol
          <volume>66</volume>
<year>2009</year>
<fpage>1260</fpage>
<lpage>1266</lpage>
<pub-id pub-id-type="pmid">19822782</pub-id>
</element-citation>
</ref>
<ref id="bib68">
<label>68</label>
<element-citation id="sref70" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>AlAsiri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Basit</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wood-Trageser</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Yatsenko</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Jeffries</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Surti</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability</article-title>
<source/>J Clin Invest
          <volume>125</volume>
<year>2015</year>
<fpage>258</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="pmid">25437880</pub-id>
</element-citation>
</ref>
<ref id="bib69">
<label>69</label>
<element-citation id="sref71" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tenenbaum-Rakover</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Weinberg-Shukron</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Renbaum</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lobel</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Eideh</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gulsuner</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Minichromosome maintenance complex component 8 (MCM8) gene mutations result in primary gonadal failure</article-title>
<source/>J Med Genet
          <volume>52</volume>
<year>2015</year>
<fpage>391</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="pmid">25873734</pub-id>
</element-citation>
</ref>
<ref id="bib70">
<label>70</label>
<element-citation id="sref72" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouali</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Francou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bouligand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Imanci</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dimassi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tosca</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>New MCM8 mutation associated with premature ovarian insufficiency and chromosomal instability in a highly consanguineous Tunisian family</article-title>
<source/>Fertil Steril
          <volume>108</volume>
<year>2017</year>
<fpage>694</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="pmid">28863940</pub-id>
</element-citation>
</ref>
<ref id="bib71">
<label>71</label>
<element-citation id="sref73" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>ZJ</given-names>
</name>
</person-group>
<article-title>Minichromosome maintenance complex component 8 mutations cause primary ovarian insufficiency</article-title>
<source/>Fertil Steril
          <volume>106</volume>
<year>2016</year>
<fpage>1485</fpage>
<lpage>1489.e2</lpage>
<pub-id pub-id-type="pmid">27573988</pub-id>
</element-citation>
</ref>
<ref id="bib72">
<label>72</label>
<element-citation id="sref74" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruth</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Lessons from Genome-Wide Association Studies in Reproductive Medicine: Menopause</article-title>
<source/>Semin Reprod Med
          <volume>34</volume>
<year>2016</year>
<fpage>215</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="pmid">27513022</pub-id>
</element-citation>
</ref>
<ref id="bib73">
<label>73</label>
<element-citation id="sref75" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Fernandez-Rhodes</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brzyski</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Heiss</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Replication of loci influencing ages at menarche and menopause in Hispanic women: the Women’s Health Initiative SHARe Study</article-title>
<source/>Hum Mol Genet
          <volume>21</volume>
<year>2012</year>
<fpage>1419</fpage>
<lpage>1432</lpage>
<pub-id pub-id-type="pmid">22131368</pub-id>
</element-citation>
</ref>
<ref id="bib74">
<label>74</label>
<element-citation id="sref76" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Dreyfus</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Meta-analysis of loci associated with age at natural menopause in African-American women</article-title>
<source/>Hum Mol Genet
          <volume>23</volume>
<year>2014</year>
<fpage>3327</fpage>
<lpage>3342</lpage>
<pub-id pub-id-type="pmid">24493794</pub-id>
</element-citation>
</ref>
<ref id="bib75">
<label>75</label>
<element-citation id="sref77" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stolk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van Meurs</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Verbiest</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Visser</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Estrada</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Loci at chromosomes 13, 19 and 20 influence age at natural menopause</article-title>
<source/>Nat Genet
          <volume>41</volume>
<year>2009</year>
<fpage>645</fpage>
<lpage>647</lpage>
<pub-id pub-id-type="pmid">19448619</pub-id>
</element-citation>
</ref>
<ref id="bib76">
<label>76</label>
<element-citation id="sref78" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Day</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Ruth</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Lunetta</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Pervjakova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chasman</surname>
<given-names>DI</given-names>
</name>
</person-group>
<article-title>Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair</article-title>
<source/>Nat Genet
          <volume>47</volume>
<year>2015</year>
<fpage>1294</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="pmid">26414677</pub-id>
</element-citation>
</ref>
<ref id="bib77">
<label>77</label>
<element-citation id="sref79" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bond</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mochida</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Hampshire</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Askham</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>ASPM is a major determinant of cerebral cortical size</article-title>
<source/>Nat Genet
          <volume>32</volume>
<year>2002</year>
<fpage>316</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="pmid">12355089</pub-id>
</element-citation>
</ref>
<ref id="bib78">
<label>78</label>
<element-citation id="sref80" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Evolution of the human ASPM gene, a major determinant of brain size</article-title>
<source/>Genetics
          <volume>165</volume>
<year>2003</year>
<fpage>2063</fpage>
<lpage>2070</lpage>
<pub-id pub-id-type="pmid">14704186</pub-id>
</element-citation>
</ref>
<ref id="bib79">
<label>79</label>
<element-citation id="sref81" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mekel-Bobrov</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Vallender</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>RR</given-names>
</name>
</person-group>
<article-title>Ongoing adaptive evolution of ASPM, a brain size determinant in Homo sapiens</article-title>
<source/>Science
          <volume>309</volume>
<year>2005</year>
<fpage>1720</fpage>
<lpage>1722</lpage>
<pub-id pub-id-type="pmid">16151010</pub-id>
</element-citation>
</ref>
<ref id="bib80">
<label>80</label>
<element-citation id="sref82" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steffener</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Exploring the neural basis of cognitive reserve in aging</article-title>
<source/>Biochim Biophys Acta
          <volume>1822</volume>
<year>2012</year>
<fpage>467</fpage>
<lpage>473</lpage>
<pub-id pub-id-type="pmid">21982946</pub-id>
</element-citation>
</ref>
<ref id="bib81">
<label>81</label>
<element-citation id="sref83" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satz</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory</article-title>
<source/>Neuropsychology
          <volume>7</volume>
<year>1993</year>
<fpage>273</fpage>
<lpage>295</lpage>
</element-citation>
</ref>
<ref id="bib82">
<label>82</label>
<element-citation id="sref84" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitwell</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>The protective role of brain size in Alzheimer's disease</article-title>
<source/>Expert Rev Neurother
          <volume>10</volume>
<year>2010</year>
<fpage>1799</fpage>
<lpage>1801</lpage>
<pub-id pub-id-type="pmid">21091311</pub-id>
</element-citation>
</ref>
<ref id="bib83">
<label>83</label>
<element-citation id="sref85" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katzman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Terry</surname>
<given-names>R</given-names>
</name>
<name>
<surname>DeTeresa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fuld</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques</article-title>
<source/>Ann Neurol
          <volume>23</volume>
<year>1988</year>
<fpage>138</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="pmid">2897823</pub-id>
</element-citation>
</ref>
<ref id="bib84">
<label>84</label>
<element-citation id="sref86" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Julin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gertz</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Winblad</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wahlund</surname>
<given-names>LO</given-names>
</name>
</person-group>
<article-title>Intracranial volume in mild cognitive impairment, Alzheimer’s disease and vascular dementia: evidence for brain reserve?</article-title>
<source/>Int J Geriatr Psychiatry
          <volume>19</volume>
<year>2004</year>
<fpage>995</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="pmid">15449362</pub-id>
</element-citation>
</ref>
<ref id="bib85">
<label>85</label>
<element-citation id="sref87" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aguirre</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Baudry</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices</article-title>
<source/>Eur J Neurosci
          <volume>29</volume>
<year>2009</year>
<fpage>447</fpage>
<lpage>454</lpage>
<pub-id pub-id-type="pmid">19175406</pub-id>
</element-citation>
</ref>
<ref id="bib86">
<label>86</label>
<element-citation id="sref88" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cadenas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brinton</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Estrogen protection against mitochondrial toxin-induced cell death in hippocampal neurons: antagonism by progesterone</article-title>
<source/>Brain Res
          <volume>1379</volume>
<year>2011</year>
<fpage>2</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">21134358</pub-id>
</element-citation>
</ref>
<ref id="bib87">
<label>87</label>
<element-citation id="sref89" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woolley</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>B.S.</given-names>
</name>
</person-group>
<article-title>Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat</article-title>
<source/>J Comp Neurol
          <volume>336</volume>
<year>1993</year>
<fpage>293</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="pmid">8245220</pub-id>
</element-citation>
</ref>
<ref id="bib88">
<label>88</label>
<element-citation id="sref90" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imtiaz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Taipale</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tanskanen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tiihonen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kivipelto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Heikkinen</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Risk of Alzheimer’s disease among users of postmenopausal hormone therapy: A nationwide case-control study</article-title>
<source/>Maturitas
          <volume>98</volume>
<year>2017</year>
<fpage>7</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">28274328</pub-id>
</element-citation>
</ref>
<ref id="bib89">
<label>89</label>
<element-citation id="sref91" publication-type="book">
<source/>Conference, AsAI, Pregnancy and Reproductive History May Impact Dementia Risk Plus, the Move to Re-Think the Impact of Hormone Therapy on Cognition
          <year>2018</year>
</element-citation>
</ref>
<ref id="bib90">
<label>90</label>
<element-citation id="sref92" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heuer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Cintron</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>LC</given-names>
</name>
</person-group>
<article-title>Nonhuman primate models of Alzheimer-like cerebral proteopathy</article-title>
<source/>Curr Pharm Des
          <volume>18</volume>
<year>2012</year>
<fpage>1159</fpage>
<lpage>1169</lpage>
<pub-id pub-id-type="pmid">22288403</pub-id>
</element-citation>
</ref>
<ref id="bib91">
<label>91</label>
<element-citation id="sref93" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
</person-group>
<article-title>Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways</article-title>
<source/>Proc Natl Acad Sci U S A
          <volume>107</volume>
<year>2010</year>
<fpage>12698</fpage>
<lpage>12703</lpage>
<pub-id pub-id-type="pmid">20616000</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="appsec1" sec-type="supplementary-material">
<title>Supplementary Data</title>
<p id="p0170">
<supplementary-material content-type="local-data" id="ec1">
<caption>
<title>Supplementary Data</title>
</caption>
<media xlink:href="mmc1.docx"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="ec2">
<caption>
<title>Supplementary Tables</title>
</caption>
<media xlink:href="mmc2.xlsx"></media>
</supplementary-material>
</p>
</sec>
<ack id="ack0010">
<title>Acknowledgements</title>
<p>The authors acknowledge the Alzheimer's Disease Sequencing Project for providing the exome sequencing data. The Alzheimer's Disease Sequencing Project (ADSP) comprised two Alzheimer's Disease (AD) genetics consortia and three National Human Genome Research Institute (NHGRI)–funded <funding-source id="gs28">Large-Scale Sequencing Centers</funding-source> (LSSC). The two AD genetics consortia are the Alzheimer's Disease Genetics Consortium (ADGC) funded by <funding-source id="gs3">NIA</funding-source> (U01 AG032984) and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) funded by <funding-source id="gs4">NIA</funding-source> (R01 AG033193), the <funding-source id="gs5">National Heart, Lung, and Blood Institute</funding-source> (NHLBI), other <funding-source id="gs29">National Institute of Health</funding-source> (NIH) institutes, and other foreign governmental and nongovernmental organizations. The discovery phase analysis of sequence data is supported through UF1AG047133 to Drs. Schellenberg, Farrer, Pericak-Vance, Mayeux, and Haines; U01AG049505 to Dr. Seshadri; U01AG049506 to Dr. Boerwinkle; U01AG049507 to Dr. Wijsman; and U01AG049508 to Dr. Goate. The ADGC cohorts include Adult Changes in Thought (ACT), the Alzheimer's Disease Centers (ADC), the Chicago Health and Aging Project (CHAP), the Memory and Aging Project (MAP), Mayo Clinic (MAYO), Mayo Parkinson's Disease controls, University of Miami, the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study (MIRAGE), the National Cell Repository for Alzheimer's Disease (NCRAD), the National Institute on Aging Late Onset Alzheimer's Disease Family Study (NIA-LOAD), the Religious Orders Study (ROS), the Texas Alzheimer's Research and Care Consortium (TARC), Vanderbilt University/Case Western Reserve University (VAN/CWRU), the Washington Heights-Inwood Columbia Aging Project (WHICAP) and the Washington University Sequencing Project (WUSP), the Columbia University Hispanic-Estudio Familiar de Influencia Genetica de Alzheimer (EFIGA), the University of Toronto (UT), and Genetic Differences (GD). The CHARGE cohorts, with funding provided by 5RC2HL102419 and HL105756, include the following: Atherosclerosis Risk in Communities (ARIC) Study, which is carried out as a collaborative study supported by <funding-source id="gs18">NHLBI</funding-source> contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), <funding-source id="gs19">Austrian Stroke Prevention Study</funding-source> (ASPS), <funding-source id="gs30">Cardiovascular Health Study</funding-source> (CHS), <funding-source id="gs31">Erasmus Rucphen Family Study</funding-source> (ERF), <funding-source id="gs32">Framingham Heart Study</funding-source> (FHS), and <funding-source id="gs33">Rotterdam Study</funding-source> (RS).</p>
<p>The three LSSCs are the Human Genome Sequencing Center at the Baylor College of Medicine (U54 HG003273), the Broad Institute Genome Center (U54HG003067), and the Washington University Genome Institute (U54HG003079). Biological samples and associated phenotypic data used in primary data analyses were stored at the study investigators' institutions and at the National Cell Repository for Alzheimer's Disease (NCRAD, U24AG021886) at Indiana University funded by <funding-source id="gs17">NIA</funding-source>. Associated phenotypic data used in primary and secondary data analyses were provided by the study investigators, the <funding-source id="gs34">NIA</funding-source>-funded <funding-source id="gs35">Alzheimer's Disease Centers</funding-source> (ADCs), and the <funding-source id="gs36">National Alzheimer's Coordinating Center</funding-source> (NACC, U01AG016976) and the <funding-source id="gs37">National Institute on Aging Alzheimer's Disease Data Storage Site</funding-source> (NIAGADS, U24AG041689) at the <funding-source id="gs21">University of Pennsylvania</funding-source>, funded by <funding-source id="gs22">NIA</funding-source>, and at the <funding-source id="gs38">Database for Genotypes and Phenotypes</funding-source> (dbGaP) funded by <funding-source id="gs23">NIH</funding-source>. Contributors to the genetic analysis data included the study investigators of projects that were individually funded by <funding-source id="gs24">NIA</funding-source> and other <funding-source id="gs25">NIH</funding-source> institutes, and by private U.S. organizations or foreign governmental or nongovernmental organizations.</p>
<p>This work was supported by the <funding-source id="gs26">National Institutes of Health</funding-source> (NIH R01-NIA-AG039521) to B.A.J. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the article; and decision to submit the article for publication.</p>
</ack>
<fn-group>
<fn id="d31e962">
<p id="ntpara0010">The authors have declared that no conflict of interest exists.</p>
</fn>
<fn fn-type="supplementary-material" id="appsec2">
<p id="p0175">Supplementary data related to this article can be found at <ext-link ext-link-type="doi" id="intref0010" xlink:href="10.1016/j.trci.2019.09.004">https://doi.org/10.1016/j.trci.2019.09.004</ext-link>.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>